CIPO Patents = 4

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Kathleen E Clarence-Smith (4 out of 32 patents)

4 patents: Sort by Forward Citations

1. 11896582 - Use and composition for treating myasthenia gravis and other myasthenic syndromes (2024-02-13),

2. 11752141 - Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis (2023-09-12),

3. 11389420 - Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis (2022-07-19),

4. 10842778 - Use and composition for treating myasthenia gravis and other myasthenic syndromes (2020-11-24),

Das-mg, Inc. is a leading provider of strategic management consulting services. We specialize in helping businesses improve their operations, optimize their strategies, and achieve their goals. Our team of experts works closely with clients to develop tailored solutions that drive success and growth. With a focus on innovation and excellence, we are committed to delivering real, measurable results for our clients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

4 Patents

#342 in Boston, MA

#3,234 in Massachusetts

#58,998 in US

Boston, MA, United States of America

Das-mg, Inc.

Forward Citations = 1

3 inventors:

Kathleen E Clarence-Smith (4 out of 32 patents)

Please report any incorrect information to support@idiyas.com

4 patents (CIPO):

Please report any incorrect information to support@idiyas.com